elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33404541-377FA12B-2551-463A-9413-994F79B9B626
Q33404541-377FA12B-2551-463A-9413-994F79B9B626
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404541-377FA12B-2551-463A-9413-994F79B9B626
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.
P2860
Q33404541-377FA12B-2551-463A-9413-994F79B9B626
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404541-377FA12B-2551-463A-9413-994F79B9B626
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1388965960be21dd3515cb6ab0e9d0be11039d84
P2860
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial